United States · Seed startup

Who invested in GelMEDIX

2 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$14Mraised across 2 rounds since 2026, from 2 sources

$13MSeed$747KRound
Latest round
Round, $747KApr 2026
Biggest round
$13MSeed · Feb 2026
Investors
1
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2027
$13MSeed$747KRound
First round
Seed, $13M
Feb 2026
Biggest round
$13M
Seed · Feb 2026
Between rounds
3 months
from the last two

The rounds

  1. Apr 2026
    Round$747K

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $747K sold, first sale Apr 2026

  2. Feb 2026
    Seed$13M1 new

    Source recordedSEC filing: $542K sold, first sale Oct 2025

Founders and team

From GelMEDIX's own website: 1 on the team.

  • Arthur SperosSenior Research Associate

Everyone who backed them

Safar PartnersVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about GelMEDIX

Who invested in GelMEDIX?

GelMEDIX's investors include Safar Partners.

How much has GelMEDIX raised?

GelMEDIX has raised $14M across 2 rounds since 2026.

When did GelMEDIX last raise?

GelMEDIX's most recent round, $747K, was in Apr 2026.

What was GelMEDIX's biggest round?

GelMEDIX's largest round on record is $13M (Seed), in Feb 2026.

Who backed GelMEDIX first?

GelMEDIX's first round on record, in Feb 2026, was backed by Safar Partners.

What stage is GelMEDIX at?

GelMEDIX's latest named round is a Seed, in Feb 2026.

Where is GelMEDIX based?

GelMEDIX is based in the United States.

Companies like GelMEDIX

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.